Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 19194865)

1.

The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia.

Simonds J, Miller F, Mandel J, Davidson TM.

Laryngoscope. 2009 May;119(5):988-92. doi: 10.1002/lary.20159.

PMID:
19194865
2.

A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).

Zarrabeitia R, Albiñana V, Salcedo M, Señaris-Gonzalez B, Fernandez-Forcelledo JL, Botella LM.

Curr Vasc Pharmacol. 2010 Jul;8(4):473-81. Review.

PMID:
19485912
3.

Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia.

Jameson JJ, Cave DR.

Laryngoscope. 2004 Apr;114(4):705-9. Review.

PMID:
15064628
4.

[Epistaxis in patients with hereditary hemorrhagic teleangiectasia].

Jovancević L, Mitrović SM.

Med Pregl. 2006 Sep-Oct;59(9-10):443-9. Review. Serbian.

PMID:
17345820
5.

Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management.

Sautter NB, Smith TL.

Int Forum Allergy Rhinol. 2012 Sep-Oct;2(5):422-31. doi: 10.1002/alr.21046. Epub 2012 May 7. Review.

PMID:
22566463
6.

[Nasal cavity dermoplasty as a treatment of recurrent bleeding in Rendu-Osler-Weber's disease].

Kłos A, Golqbek W, Morshed K.

Otolaryngol Pol. 2007;61(1):74-9. Review. Polish.

PMID:
17605423
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk